Senti Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio11.4814.43105.23
P/B Ratio0.320.440.494.81
Price/Tangible Book0.630.440.49
Enterprise Value Ratios
EV/Revenue10.40
Profitability & Returns
Return on Equity (ROE)-0.90%-0.86%-0.53%-1.21%-0.81%
Return on Assets (ROA)-0.31%-0.27%-0.28%-0.35%-0.37%
Return on Capital Employed (ROCE)-0.64%-0.60%-0.38%-0.49%-0.57%
Leverage & Solvency Ratios
Debt/Equity0.660.560.290.380.45
Liquidity Ratios
Current Ratio4.495.625.684.146.52
Quick Ratio3.834.245.563.976.35
Efficiency Ratios
Asset Turnover0.020.030.040.01
Yield & Distribution Ratios
Earnings Yield-3.28%-2.42%-0.94%-0.19%
FCF Yield-2.57%-2.19%-1.23%-0.14%
Buyback Yield-0.04%-0.70%-7.97%0.79%-0.02%